首页> 外文期刊>The Journal of craniofacial surgery >Endoscopic Versus Microscopic Transsphenoidal Surgery for Pituitary Tumors
【24h】

Endoscopic Versus Microscopic Transsphenoidal Surgery for Pituitary Tumors

机译:内镜与显微经蝶窦手术治疗垂体瘤

获取原文
获取原文并翻译 | 示例
           

摘要

Background:To compare the clinical outcomes and complications of 247 pituitary tumor patients managed by endoscopic and microscopic approaches in our hospital.Methods:The authors performed a retrospective review of 100 pituitary tumor patients treated by endoscopic endonasal transsphenoidal surgery (ETS) and 147 patients treated by microscopic transsphenoidal surgery (MTS) at our center from January 2007 to July 2014. The tumors were stratified by Knosp classification and modified Hardy classification, and tumor gross total resection (GTR)/remission rate, visual improvement rate, complications, operation time, intraoperative bleeding and length of hospital stay were compared between ETS and MTS.Results:The GTR rate decreased with increasing Knosp grades for both ETS and MTS, with the rates of 93.3%, 87.5%, 71.4%, 58.8% for ETS and 82.8%, 92.0%, 70.7%, 36.0% for MTS in resecting Knosp grades 0, I, II, and III tumors, respectively. The visual improvement rates increased with increasing Hardy grades, which was 66.7% and 45.5% for Hardy grade B lesion, 72.2% and 71.4% for grade C lesion, and 88.9% and 78.9% for grade D lesion treated by ETS and MTS, respectively. No significant differences were observed for GTR rate, visual outcome and complication rate between ETS and MTS, while ETS resulted in more intraoperative blood loss, longer operative time, and shorter hospital stay than MTS.Conclusions:These data conclude that, compared with MTS, ETS needs longer operation time and results in more intraoperative blood loss, but appears to achieve higher GTR rate for Knosp grade III pituitary tumors.
机译:背景:比较我院内镜和镜下手术治疗的247例垂体瘤患者的临床结局和并发症。方法:作者回顾性回顾了100例经鼻内镜经鼻蝶窦内手术治疗的垂体瘤患者和147例经治疗的垂体瘤患者。通过我们中心2007年1月至2014年7月的显微经蝶窦手术(MTS)进行分类。按照诺氏(Knosp)分类和改良的哈代(Hardy)分类对肿瘤进行分层,并对肿瘤的总总切除率(GTR)/缓解率,视觉改善率,并发症,手术时间,结果:ETS和MTS的GTR率随Knosp等级的升高而降低,ETS和MTS的GTR率分别为93.3%,87.5%,71.4%,58.8%和82.8%。切除Knosp 0,I,II和III级肿瘤的MTS分别为92.0%,70.7%,36.0%。视力改善率随Hardy等级的增加而增加,经ETS和MTS治疗的Hardy B级病变分别为66.7%和45.5%,C级病变为72.2%和71.4%,D级病变分别为88.9%和78.9%。 。与MTS相比,ETS和MTS之间的GTR率,视觉结果和并发症发生率没有显着差异,而ETS导致术中失血更多,手术时间更长,住院时间更短。结论:这些数据表明,与MTS相比, ETS需要更长的手术时间并导致更多的术中失血,但对于Knosp III级垂体肿瘤,似乎可以达到更高的GTR率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号